Codexis (CDXS) Long-Term Investments (2010 - 2026)
Codexis' (CDXS) quarterly Long-Term Investments came in at $2.5 million in Q1 2026, down 10.72% year-on-year from $2.8 million in Q1 2025, and little changed quarter-over-quarter from $2.5 million in Q4 2025.
Codexis (CDXS) Long-Term Investments (2010 - 2026) Analysis & Trends
Codexis' Long-Term Investments history runs 17 years deep, the most recent figure standing at $2.5 million for Q1 2026.
- On a quarterly basis, Long-Term Investments fell 10.72% year-over-year to $2.5 million in Q1 2026; TTM through Mar 2026 was $2.5 million, a 10.72% decrease from a year earlier, with the FY2025 full-year figure at $2.5 million, down 10.72% from the prior year.
- Long-Term Investments steadied at $2.5 million in Q1 2026 per CDXS's latest filing, from $2.5 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $21.4 million in Q2 2023 and bottomed at $400000.0 in Q3 2023.
- The 5-year median for Long-Term Investments is $5.8 million (2024), against an average of $9.4 million.
- Across the five-year window, Long-Term Investments plunged 98.05% in 2023 and jumped 1347.5% in 2024, its largest moves.
- Year by year, Long-Term Investments stood at $20.5 million in 2022, then sank by 52.71% to $9.7 million in 2023, then tumbled by 71.15% to $2.8 million in 2024, then retreated by 10.72% to $2.5 million in 2025, then changed by 0.0% to $2.5 million in 2026.
- Per Business Quant, the three latest CDXS Long-Term Investments figures stand at $2.5 million (Q1 2026), $2.5 million (Q4 2025), and $2.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 505,194.89 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Codexis | 180.63 Mn | 115.49 Mn | 13.18 Mn | 2.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.50 Mn |
| Dec 31, 2025 | 2.50 Mn |
| Sep 30, 2025 | 2.80 Mn |
| Jun 30, 2025 | 2.80 Mn |
| Mar 31, 2025 | 2.80 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Sep 30, 2024 | 5.79 Mn |
| Jun 30, 2024 | 9.70 Mn |
| Mar 31, 2024 | 9.70 Mn |
| Dec 31, 2023 | 9.70 Mn |
| Sep 30, 2023 | 400,000.00 |
| Jun 30, 2023 | 21.38 Mn |
| Mar 31, 2023 | 21.31 Mn |
| Dec 31, 2022 | 20.51 Mn |
| Sep 30, 2022 | 20.51 Mn |
| Jun 30, 2022 | 19.30 Mn |
| Mar 31, 2022 | 5.00 Mn |
| Dec 31, 2021 | 14.00 Mn |
| Sep 30, 2021 | 12.76 Mn |
| Jun 30, 2021 | 3.40 Mn |